Skip to main content

Emster Kurt Von's Form 4 filing

CymaBay Therapeutics, Inc. (CBAY) · filed Sep 29, 2023

Accession no.
0001062993-23-018622
Filed
Sep 29, 2023
Trade date
Sep 29, 2023
Filing delay
Same day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 4 derivative transactions. Open-market sales total $249.6K. It was filed on the trade date.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Emster Kurt VonCIK 0001252524Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 29, 2023Common StockMOption exerciseAcquired+15,921$5.00+$79,605105,921Direct
Sep 29, 2023Common StockSSaleDisposed−15,921$15.68−$249,641.2890,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 29, 2023Common StockMOption exerciseDisposed−6,357$0.00$00Direct
Sep 29, 2023Common StockMOption exerciseDisposed−943$0.00$00Direct
Sep 29, 2023Common StockMOption exerciseDisposed−3,372$0.00$00Direct
Sep 29, 2023Common StockMOption exerciseDisposed−5,249$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)